» Articles » PMID: 16445852

Expression of Arginine Decarboxylase in Brain Regions and Neuronal Cells

Overview
Journal J Neurochem
Specialties Chemistry
Neurology
Date 2006 Feb 1
PMID 16445852
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

After our initial report of a mammalian gene for arginine decarboxylase, an enzyme for the synthesis of agmatine from arginine, we have determined the regional expression of ADC in rat. We have analyzed the expression of ADC in rat brain regions by activity, protein and mRNA levels, and the regulation of expression in neuronal cells by RNA interference. In rat brain, ADC was widely expressed in major brain regions, with a substantial amount in hypothalamus, followed by cortex, and with least amounts in locus coeruleus and medulla. ADC mRNA was detected in primary astrocytes and C6 glioma cells. While no ADC message was detected in fresh neurons (3 days old), significant message appeared in differentiated neurons (3 weeks old). PC12 cells, treated with nerve growth factor, had higher ADC mRNA compared with naive cells. The siRNA mixture directed towards the N-terminal regions of ADC cDNA down-regulated the levels of mRNA and protein in cultured neurons/C6 glioma cells and these cells produced lower agmatine. Thus, this study demonstrates that ADC message is expressed in rat brain regions, that it is regulated in neuronal cells and that the down-regulation of ADC activity by specific siRNA leads to lower agmatine production.

Citing Articles

Agmatine suppresses glycolysis via the PI3K/Akt/mTOR/HIF-1α signaling pathway and improves mitochondrial function in microglia exposed to lipopolysaccharide.

Milosevic K, Milosevic A, Stevanovic I, Zivkovic A, Laketa D, Janjic M Biofactors. 2025; 51(1):e2149.

PMID: 39888089 PMC: 11780571. DOI: 10.1002/biof.2149.


Polyamines: Key Players in Immunometabolism and Immune Regulation.

Mahalingam S, Pandiyan P J Cell Immunol. 2024; 6(5):196-208.

PMID: 39717382 PMC: 11666123. DOI: 10.33696/immunology.6.206.


Possible Role of Cellular Polyamine Metabolism in Neuronal Apoptosis.

Ji X, Yu W, Jin M, Lu L, Yin H, Wang H Curr Med Sci. 2024; 44(2):281-290.

PMID: 38453792 DOI: 10.1007/s11596-024-2843-9.


Good cop, bad cop: Polyamines play both sides in host immunity and viral replication.

Cruz-Pulido Y, Mounce B Semin Cell Dev Biol. 2023; 146:70-79.

PMID: 36604249 PMC: 10101871. DOI: 10.1016/j.semcdb.2022.12.004.


Neural Stem Cells Overexpressing Arginine Decarboxylase Improve Functional Recovery from Spinal Cord Injury in a Mouse Model.

Park Y, Kim J, Lee J Int J Mol Sci. 2022; 23(24).

PMID: 36555425 PMC: 9779865. DOI: 10.3390/ijms232415784.


References
1.
Reis D, Regunathan S . Is agmatine a novel neurotransmitter in brain?. Trends Pharmacol Sci. 2000; 21(5):187-93. DOI: 10.1016/s0165-6147(00)01460-7. View

2.
Feng Y, Leblanc M, Regunathan S . Agmatine reduces extracellular glutamate during pentylenetetrazole-induced seizures in rat brain: a potential mechanism for the anticonvulsive effects. Neurosci Lett. 2005; 390(3):129-33. PMC: 2920494. DOI: 10.1016/j.neulet.2005.08.008. View

3.
Fairbanks C, Schreiber K, Brewer K, Yu C, Stone L, Kitto K . Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proc Natl Acad Sci U S A. 2000; 97(19):10584-9. PMC: 27068. DOI: 10.1073/pnas.97.19.10584. View

4.
Yu C, Marcillo A, Fairbanks C, Wilcox G, Yezierski R . Agmatine improves locomotor function and reduces tissue damage following spinal cord injury. Neuroreport. 2000; 11(14):3203-7. DOI: 10.1097/00001756-200009280-00031. View

5.
Gilad G, Gilad V . Accelerated functional recovery and neuroprotection by agmatine after spinal cord ischemia in rats. Neurosci Lett. 2000; 296(2-3):97-100. DOI: 10.1016/s0304-3940(00)01625-6. View